Anita S. Kablinger

1.0k total citations · 1 hit paper
50 papers, 641 citations indexed

About

Anita S. Kablinger is a scholar working on Clinical Psychology, Psychiatry and Mental health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anita S. Kablinger has authored 50 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Clinical Psychology, 15 papers in Psychiatry and Mental health and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Anita S. Kablinger's work include Schizophrenia research and treatment (7 papers), Obsessive-Compulsive Spectrum Disorders (4 papers) and Sleep and related disorders (4 papers). Anita S. Kablinger is often cited by papers focused on Schizophrenia research and treatment (7 papers), Obsessive-Compulsive Spectrum Disorders (4 papers) and Sleep and related disorders (4 papers). Anita S. Kablinger collaborates with scholars based in United States, China and Taiwan. Anita S. Kablinger's co-authors include Abuhuziefa Abubakr, Gloria Caldito, Donard S. Dwyer, Ronald J. Bradley, Warren K. Bickel, Mikhail N. Koffarnus, Arthur M. Freeman, A. J. Freeman, Patrick B. Wood and Tanya K. Murphy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Anita S. Kablinger

47 papers receiving 611 citations

Hit Papers

Semaglutide and Tirzepati... 2023 2026 2024 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity
    2023 76 citations Allison N. Tegge, Anita S. Kablinger et al. Scientific Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anita S. Kablinger United States 14 216 133 96 84 80 50 641
Jerzy Landowski Poland 19 330 1.5× 124 0.9× 71 0.7× 56 0.7× 81 1.0× 90 895
José Antonio Monreal Spain 17 349 1.6× 241 1.8× 75 0.8× 173 2.1× 71 0.9× 84 917
David A. Barton Australia 11 137 0.6× 131 1.0× 37 0.4× 65 0.8× 85 1.1× 18 1.0k
Bjanka Vuksan‐Ćusa Croatia 17 292 1.4× 194 1.5× 37 0.4× 70 0.8× 51 0.6× 36 694
Markus Banger Germany 16 130 0.6× 69 0.5× 101 1.1× 116 1.4× 134 1.7× 43 691
Sang‐Woo Hahn South Korea 15 172 0.8× 148 1.1× 45 0.5× 75 0.9× 55 0.7× 45 589
Manuel Arrojo Spain 18 300 1.4× 227 1.7× 57 0.6× 33 0.4× 110 1.4× 64 821
Ali Çayköylü Türkiye 16 325 1.5× 203 1.5× 72 0.8× 27 0.3× 41 0.5× 68 714
Javier Vázquez-Bourgón Spain 16 464 2.1× 142 1.1× 38 0.4× 108 1.3× 54 0.7× 77 793
Ruth Ohlsen United Kingdom 14 439 2.0× 98 0.7× 63 0.7× 47 0.6× 60 0.8× 38 708

Countries citing papers authored by Anita S. Kablinger

Since Specialization
Citations

This map shows the geographic impact of Anita S. Kablinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita S. Kablinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita S. Kablinger more than expected).

Fields of papers citing papers by Anita S. Kablinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anita S. Kablinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita S. Kablinger. The network helps show where Anita S. Kablinger may publish in the future.

Co-authorship network of co-authors of Anita S. Kablinger

This figure shows the co-authorship network connecting the top 25 collaborators of Anita S. Kablinger. A scholar is included among the top collaborators of Anita S. Kablinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anita S. Kablinger. Anita S. Kablinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Yezhe, Hillary Samples, Greta Bushnell, et al.. (2025). The prevalence of comorbidities in people with psychogenic non-epileptic seizures (2013–2023). Epilepsy & Behavior. 168. 110420–110420. 1 indexed citations
3.
Kablinger, Anita S., et al.. (2024). Assessing the impact of COVID-19 on outpatient psychiatric population well-being and symptomology utilizing COVID-19 Events Checklist (CEC) and Measurement Based Care. Journal of Patient-Reported Outcomes. 8(1). 135–135. 1 indexed citations
4.
Brown, Tashalee R., Anita S. Kablinger, Robert L. Trestman, et al.. (2024). Psychiatric comorbidities in children with conduct disorder: a descriptive analysis of real-world data. General Psychiatry. 37(2). e101501–e101501. 4 indexed citations
5.
6.
Sun, Ching-Fang, et al.. (2024). Benzodiazepine use for anxiety disorders is associated with increased long-term risk of mood and substance use disorders: A large-scale retrospective cohort study. SHILAP Revista de lepidopterología. 12. 100270–100270. 3 indexed citations
7.
8.
Hutchings, Kate, et al.. (2023). Donepezil-induced psychosis: a cautionary report of a rare adverse reaction. European Psychiatry. 66(S1). S357–S358. 1 indexed citations
9.
Kablinger, Anita S., et al.. (2022). Effects of COVID-19 on Patients in Adult Ambulatory Psychiatry: Using Patient-Rated Outcome Measures and Telemedicine. Telemedicine Journal and e-Health. 28(10). 1421–1430. 8 indexed citations
10.
Rahmani, Elham, et al.. (2022). A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population. Journal of Clinical Pharmacy and Therapeutics. 47(12). 2083–2090. 2 indexed citations
11.
12.
Kablinger, Anita S., et al.. (2020). A Case of Cachexia Secondary to Obsessive-Compulsive Disorder. SHILAP Revista de lepidopterología. 2020. 1–4. 2 indexed citations
13.
Kablinger, Anita S., et al.. (2013). Controversies in the use of second generation antipsychotics as sleep agent. Pharmacological Research. 79. 1–8. 16 indexed citations
14.
Sethi, Roopa, et al.. (2012). Serotonin Syndrome in a Sertraline-Treated Man Taking NyQuil Containing Dextromethorphan for Cold. The Primary Care Companion For CNS Disorders. 14(6). 4 indexed citations
15.
Kablinger, Anita S., et al.. (2012). Training General Psychiatry Residents To Prescribe Buprenorphine in Treatment of Patients With Opioid Dependence. Journal of Graduate Medical Education. 4(3). 391–391. 1 indexed citations
16.
Kablinger, Anita S., et al.. (2005). Medications for Panic Disorder and Generalized Anxiety Disorder During Pregnancy. The Primary Care Companion For CNS Disorders. 7(3). 100–5. 26 indexed citations
17.
Wood, Patrick B., et al.. (2005). Open Trial of Pindolol in the Treatment of Fibromyalgia. Annals of Pharmacotherapy. 39(11). 1812–1816. 34 indexed citations
18.
Abubakr, Abuhuziefa, Anita S. Kablinger, & Gloria Caldito. (2003). Psychogenic seizures: clinical features and psychological analysis. Epilepsy & Behavior. 4(3). 241–245. 89 indexed citations
19.
Dwyer, Donard S., Ronald J. Bradley, Anita S. Kablinger, & Arthur M. Freeman. (2001). Glucose metabolism in relation to schizophrenia and antipsychotic drug treatment.. Annals of Clinical Psychiatry. 13(2). 103–113. 51 indexed citations
20.
Kablinger, Anita S. & Arthur M. Freeman. (2000). M100907 in schizophrenic and schizoaffective patients. European Neuropsychopharmacology. 10. 290–290. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerzy Landowski Breakdown of academic impact, for papers by José Antonio Monreal Breakdown of academic impact, for papers by David A. Barton Breakdown of academic impact, for papers by Bjanka Vuksan‐Ćusa Breakdown of academic impact, for papers by Markus Banger Breakdown of academic impact, for papers by Sang‐Woo Hahn Breakdown of academic impact, for papers by Manuel Arrojo Breakdown of academic impact, for papers by Ali Çayköylü Breakdown of academic impact, for papers by Javier Vázquez-Bourgón Breakdown of academic impact, for papers by Ruth Ohlsen
Rankless by CCL
2026